Ranomics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.23M
Latest Deal Amount
  • Investors
  • 5

Ranomics General Information

Description

Provider of drug discovery and genomics screening services intended to improve understanding of human genetics. The company's services offer variation to develop a database of rare genetic variations and offer health predictions based on the patient's genetic information, enabling patients to get genetic change variation in a cost-effectively and quick way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Services
Primary Office
  • 3404 American Drive
  • Mississauga, Ontario L4V 1T4
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ranomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 02-Sep-2016 $1.23M 00.000 Completed Generating Revenue
4. Accelerator/Incubator 05-Aug-2016 0000 Completed Generating Revenue
3. Grant 05-Jun-2015 00000 0000 Completed Startup
2. Accelerator/Incubator 19-Jan-2015 $50K $50K Completed Startup
1. Seed Round 19-Jan-2015 Completed Startup
To view Ranomics’s complete valuation and funding history, request access »

Ranomics Patents

Ranomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3020548-A1 Analysis system and method for characterizing mutations at splice junctions, identification of variants at splice junctions and splicing repair agents Pending 12-Oct-2018 000000000
CA-2944638-A1 Pcr-based method for generating multisite saturation mutagenic dna librairies Pending 07-Oct-2016 00000000000
US-10570386-B2 Pcr-based method for generating multisite saturation mutagenic dna libraries Active 07-Oct-2016 0000000000
US-20190382754-A1 Pcr-based method for generating multisite saturation mutagenic dna libraries Granted 07-Oct-2016 C12N15/1031

Ranomics Executive Team (4)

Name Title Board Seat Contact Info
Leo Wan Ph.D Co-Founder, Chief Scientific Officer & Chief Executive Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Ranomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ranomics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SOSV Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority 000 0000 000000 0
Thiel Fellowship Not-For-Profit Venture Capital 000 0000 000000 0
Hedgewood Asset Manager Minority 000 0000 000000 0
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
To view Ranomics’s complete investors history, request access »